Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
0001104659-13-085977
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-11-20 12:54:15
Reporting Period:
2013-09-30
Filing Date:
2013-11-20
Accepted Time:
2013-11-20 12:54:15
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1410939 Ophthotech Corp. OPHT Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1252522 Nicholas Galakatos C/o Clarus Ventures, Llc,
101 Main Street, Suite 1210
Cambridge MA 02142
Yes No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-09-30 2,500 $22.00 2,500 No 4 P Direct
Common Stock Acquisiton 2013-09-30 2,500 $22.00 2,500 No 4 P Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Indirect See Footnote
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 3,054,744 Indirect See Footnote
Footnotes
  1. These shares are held by AAG Peakham Trust LLC. Dr. Galakatos is a manager of AAG Peakham Trust LLC.
  2. Reflects 3,054,744 shares of Common Stock held of record by Clarus Lifesciences II, L.P. ("Clarus"). Clarus Ventures II GP, L.P. (the "GPLP"), as the sole general partner of Clarus, may be deemed to beneficially own certain of the shares held of record by Clarus. The GPLP disclaims beneficial ownership of all shares held of record by Clarus in which the GPLP does not have an actual pecuniary interest. Clarus Ventures II, LLC (the "GPLLC"), as the sole general partner of the GPLP, may be deemed to beneficially own certain of the shares held of record by Clarus. The GPLLC disclaims beneficial ownership of all shares held of record by Clarus in which the GPLLC does not have an actual pecuniary interest.
  3. Dr. Galakatos, together with other individuals identified in filings made by Clarus, each as individual Managing Directors of the GPLLC, may be deemed to beneficially own certain of the shares held of record by Clarus. Dr. Galakatos disclaims beneficial ownership of all shares held of record by Clarus in which he does not have an actual pecuniary interest. The 3,054,744 shares of Common Stock held of record by Clarus constitute shares of Common Stock issued upon the conversion of preferred stock, including shares of preferred stock issued as accrued stock dividends, in connection with the closing of the issuer's initial public offering, which shares were previously reported on a Form 4 filed on October 2, 2013.